Investment analyst with two-year forecast for Novo: Expected to lay off up to 5,000 employees

Expectations for Novo’s future earnings have now fallen so much that the company is being forced to take a serious look at its costs, according to an analyst and an investment economist.

“There was no decision harder for me than the decision to lay off 9,000 employees,” Mike Doustdar said at Novo Nordisk's annual general meeting on Thursday. Now, an investment analyst believes he will soon be forced to lay off more employees. | Photo: Tom Little

30 March 2026at 08:23

By all accounts, Novo Nordisk will likely have to carry out another major round of layoffs within the next two years if the company’s costs are to keep pace with its revenue.

Already a subscriber?Log in here

Get access to all of MedWatch

Personal subscription
Yearly payment

Save19%

Full access for one person

€925.00

/ year^*

Excl. VAT
Price incl. VAT shown at checkout

Personal subscription
Quarterly payment

Full access for one person

€286.00

/ quarter^**

Excl. VAT
Price incl. VAT shown at checkout

Company subscription
Multiple users

Full access for multiple users

Attractive price per user

Try MedWatch for 14 days - and get access to all content.

Get a non-binding trial subscription here.

^*Continues as a recurring subscription and is billed annually. Can be terminated after 5 months of subscription with 1 month's notice at the end of a month. Minimum price is up to

€539.58

excl. VAT corresponding to 7 months of subscription. Right of withdrawal under the Consumer Contracts Act. Read more here.

^**Continues as a recurring subscription for 3 months at a time. Minimum price

€286.00

excl. VAT. Can be terminated with 1 month's notice at the end of a 3-month period. Right of withdrawal under the Consumer Contracts Act. Read more here.